| Literature DB >> 24739900 |
Modhumita Ghosh Dasgupta1, Blessan Santhosh George1, Anil Bhatia2, Om Prakash Sidhu2.
Abstract
Withania somnifera (L.) Dunal is a valued medicinal plant with pharmaceutical applications. The present study was undertaken to analyze the salicylic acid induced leaf transcriptome of W. somnifera. A total of 45.6 million reads were generated and the de novo assembly yielded 73,523 transcript contig with average transcript contig length of 1620 bp. A total of 71,062 transcripts were annotated and 53,424 of them were assigned GO terms. Mapping of transcript contigs to biological pathways revealed presence of 182 pathways. Seventeen genes representing 12 pathogenesis-related (PR) families were mined from the transcriptome data and their pattern of expression post 17 and 36 hours of salicylic acid treatment was documented. The analysis revealed significant up-regulation of all families of PR genes by 36 hours post treatment except WsPR10. The relative fold expression of transcripts ranged from 1 fold to 6,532 fold. The two families of peroxidases including the lignin-forming anionic peroxidase (WsL-PRX) and suberization-associated anionic peroxidase (WsS-PRX) recorded maximum expression of 377 fold and 6532 fold respectively, while the expression of WsPR10 was down-regulated by 14 fold. Additionally, the most stable reference gene for normalization of qRT-PCR data was also identified. The effect of SA on the accumulation of major secondary metabolites of W. somnifera including withanoside V, withaferin A and withanolide A was also analyzed and an increase in content of all the three metabolites were detected. This is the first report on expression patterns of PR genes during salicylic acid signaling in W. somnifera.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24739900 PMCID: PMC3989240 DOI: 10.1371/journal.pone.0094803
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Details of primer pairs and amplicon size of reference genes used for normalization of qRT-PCR data in W. somnifera.
| Gene Name and ID | Sequence of Primer pairs | Amplicon length (bp) | Tm (°C) |
| Forward Primer Sequence 5′-3′ | |||
| Reverse Primer Sequence 5′-3′ | |||
| 60 S ribosomal protein L2 ( |
| 156 | 79.4 |
| Actin ( |
| 170 | 81.1 |
| Glyceraldehyde-3-phosphate dehydrogenase ( |
| 174 | 78.2 |
| α-Tubulin ( |
| 193 | 82.2 |
| ADP-ribosylation factor ( |
| 178 | 78.6 |
| Histone H2B ( |
| 188 | 78.1 |
Details of primer pairs and amplicon size of pathogenesis - related genes used for expression profiling during SA signaling.
| S. No. | PR Family | Name | Sequence similarity | Primer Pairs | Amplicon size (bp) | Tm (°C) |
| 1 | PR-1 | Pathogenesis- related protein PR-1 ( |
|
| 183 | 79.8 |
| 2 | PR-2 | β-1,3-glucanase ( |
|
| 158 | 78.5 |
| 3 | PR-3 | Class I chitinase ( |
|
| 194 | 81.9 |
| 4 | Class II chitinase ( |
|
| 175 | 80 | |
| 5 | Class IV chitinase ( |
|
| 185 | 76.1 | |
| 6 | PR-5 | Thaumatin-like protein ( |
|
| 166 | 78.1 |
| 7 | PR-6 | Cystatin-like protein ( |
|
| 196 | 79.4 |
| 8 | Serine protease inhibitor like protein ( |
|
| 171 | 76.5 | |
| 9 | PR-8 | Class III chitinase ( |
|
| 197 | 77.1 |
| 10 | PR-9 | Lignin-forming anionic peroxidase ( |
|
| 194 | 78.3 |
| 11 | Suberization-associated anionic peroxidase ( |
|
| 175 | 80.5 | |
| 12 | PR-10 | PR-10 type pathogenesis-related protein ( |
|
| 169 | 76.2 |
| 13 | PR-11 | Chitinase, class V ( |
|
| 163 | 78.4 |
| 14 | PR-12 | Defensin ( |
|
| 151 | 81.4 |
| 15 | PR-14 | Nonspecific lipid transfer protein 2 ( |
|
| 169 | 80.3 |
| 16 | Non-specific lipid-transfer protein-like protein At2g13820-like ( |
|
| 193 | 79 | |
| 17 | PR-16 | Germin-like protein subfamily 1 member 20 ( |
|
| 169 | 78.4 |
Figure 1Effect of salicylic acid on in vitro grown plantlets of W. somnifera.
0 = Plantlets immediately after application of SA; 17 h = Plantlets after 17 hours post SA treatment; 36 h = Plantlets after 36 hours post SA treatment.
Figure 2Distribution of transcript contig length in RNA-Seq data of W. somnifera.
Figure 3Gene Ontology classification of transcript contigs grouped under biological processes, molecular functions and cellular components.
Figure 4Distribution of transcript contigs to different biological pathways.
Values indicate number of transcript contig representation in each pathway. Pathways with number of transcript contigs below 280 are not shown in the chart.
Figure 5Expression profiling of Pathogenesis-related gene families in W. somnifera.
Results are mean of triplicate data from independent replications and the error bars represent standard deviation. The gene IDs are given in Table-2 and the number on each bar represent relative fold expression. Asterisk indicate statistical significance of P<0.01. 17 h = Expression of PR genes in 17 hours post SA treated leaf tissues; 36 h = Expression of PR genes in 36 hours post SA treated leaf tissues.
Estimation of secondary metabolites in control and salicylic acid treated leaf tissues of W. somnifera.
| Standards | Leaf tissue samples | ||
| Control | SA-17 | SA-36 | |
|
| ND | 0.4802±0.0500 | 0.8571±0.1010 |
|
| 0.4985±0.0600 | 0.9755±0.1002 | 1.2598±0.1025 |
|
| 0.0597±0.0164 | 0.0963±7.3000e-3 | 0.1087±0.0219 |
Mean values ±SD of µg mg−1 of dry weight of leaf sample; ND = Not Detected; Control = leaf samples from water treated plantlets; SA-17 = leaf samples from 17 hours post SA treated plantlets; SA-36 = leaf samples from 36 hours post SA treated plantlets.
Figure 6Quantitative variation in secondary metabolite content by exogenous application of salicylic acid.
Control = Metabolite content in water treated leaf tissues; SA-17 = Metabolite content in 17 hours post SA treated leaf tissues; SA-36 = Metabolite content in 36 hours post SA treated leaf tissues. Presence of withanoside V was not detected in water treated (control) leaf tissues.